Equities

Medicalgorithmics SA

MDG:WSE

Medicalgorithmics SA

Actions
Health CareMedical Equipment and Services
  • Price (PLN)26.98
  • Today's Change0.48 / 1.81%
  • Shares traded37.73k
  • 1 Year change+48.24%
  • Beta--
Data delayed at least 15 minutes, as of Apr 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Medicalgorithmics SA is a Poland-based company engaged in the advanced medical equipment and technology industry. The Company develops and manufactures system for the diagnosis of heart arrhythmia. Its product, named PocketECG, is used for remote monitoring of cardiac disorders, arrhythmia diagnosis and monitoring of heart, as well as is used for clinical drugs trials for cardiac safety. In addition, Medicalgorithmics SA provides services in the field of information technology and biotechnology, scientific research and development of natural sciences. Moreover, the Company works on the several projects, such as a device for tele-rehabilitation cardiology, software for optimizing repetitive task in hospitals, as well as devices and systems for remote description of the electrocardiography (ECG). It operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC and Medi-Lynx Cardiac Monitoring LLC.

  • Revenue in PLN (TTM)49.12m
  • Net income in PLN1.04m
  • Incorporated2010
  • Employees122.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
BrainCool AB (publ)10.85m-21.25m163.31m22.00--4.36--15.05-0.3407-0.34070.17530.57340.24182.093.321,214,417.00-47.34-47.14-56.18-70.16-50.61-149.77-195.75-391.450.7253-7.340.00--32.0678.35-34.34---11.63--
Modulight Oyj17.34m-51.11m168.77m70.00--0.7028--9.73-0.2805-0.28050.0951.310.0566-0.39882.0557,500.00-16.67-8.39-17.64-9.10123.80114.69-294.66-56.817.48--0.1051---12.48-8.20-38.69--63.60--
Svas Biosana SpA509.70m22.09m197.88m374.008.580.74593.940.38820.95520.955222.0110.990.88123.002.94--3.822.825.904.8320.8427.164.333.781.374.840.2875--21.6611.3443.6021.78----
Senzime AB (publ)13.31m-49.95m221.70m50.00--1.89--16.65-1.50-1.500.39093.140.09471.315.60---35.54-35.72-37.78-38.0023.32-20.59-375.20-558.687.08--0.0296--154.7761.90-1.09---3.69--
Bioretec Oy16.84m-16.33m240.99m37.00--6.53--14.31-0.1984-0.19840.20470.42130.55241.463.68105,594.60-53.58-67.11-65.75-97.6069.8570.97-96.98-134.054.86-4.020.0754--32.7719.77-56.82------
Paxman AB (publ)78.24m3.10m244.25m91.0079.18--24.353.120.43570.435711.03--------2,308,967.00---5.08---7.7669.6869.383.96-5.07--2.71----43.9929.35180.68------
Novacyt SA39.46m-126.83m247.45m222.00--0.4598--6.27-0.4167-0.41810.12971.770.05281.330.262241,251.13-16.9617.69-20.7123.8243.2162.82-321.4023.874.98-79.020.00360.00-77.2813.49-269.46---13.46--
Visiomed Group SA51.90m-15.25m248.36m73.00--2.52--4.79-0.0119-0.01190.04060.07760.34531.406.88174,550.70-10.44-53.01-12.11-127.0991.4641.03-30.24-99.081.70-9.310.2631--101.386.67-18.40--52.36--
Affluent Medical SAS0.00-64.70m251.38m52.00--1.40-----0.6596-0.65960.001.260.00----0.00-23.91-23.11-27.18-26.49-----------10.510.2905-------2.75---11.10--
Inspecs Group PLC1.02bn-5.00m265.06m1.67k--0.51074.390.2601-0.0109-0.01091.941.020.88642.248.68121,513.40-0.4347-1.48-0.6975-2.1550.9448.50-0.4904-1.970.86771.540.375--1.1636.4584.22--51.04--
Medicalgorithmics SA49.12m1.04m268.53m122.00209.072.8658.845.470.129-1.175.219.440.6253.969.60402,655.801.320.20691.540.269317.597.922.110.41763.63--0.0621--29.72-20.96375.23-6.67----
SDI Group PLC341.28m8.05m288.29m489.0036.231.329.740.84470.01520.01520.65280.41740.79582.086.29139,206.501.938.832.3411.4363.3464.572.4310.641.145.860.33110.0036.0936.05-48.6819.1111.86--
Optomed Oyj65.07m-19.13m326.96m114.00--3.65--5.02-0.2695-0.26950.92111.150.50021.674.92132,456.10-14.70-12.95-17.72-15.9067.8365.69-29.40-27.842.04-7.290.1926--3.003.4718.84--7.26--
OssDsign AB41.76m-48.59m334.57m----3.82--8.01-1.74-1.741.522.410.34086.546.19---39.65-38.80-44.90-44.7274.5872.29-116.35-203.054.15-30.390.0132--96.8253.26-31.30---60.35--
Mentice AB101.89m-1.05m363.71m114.00--6.1439.243.57-0.1094-0.109410.896.220.83492.403.202,400,079.00-0.8596-7.69-1.69-13.0786.3983.67-1.03-10.001.01--0.0567--25.5411.7490.81---10.83--
Data as of Apr 23 2024. Currency figures normalised to Medicalgorithmics SA's reporting currency: Polish New Zloty PLN

Institutional shareholders

3.05%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 31 Dec 2023143.11k1.44%
Lacuna Verm�gen GmbHas of 30 Jun 202176.51k0.77%
Rockbridge TFIas of 31 Dec 202057.70k0.58%
Pocztylion � Arka Powszechne Towarzystwo Emerytalne SAas of 31 Dec 202124.32k0.24%
PKO TFI SAas of 30 Jun 20201.50k0.02%
SSgA Funds Management, Inc.as of 04 Apr 202459.000.00%
PTE PZU SAas of 30 Jun 20230.000.00%
More ▼
Data from 30 Jun 2021 - 31 Jan 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.